Compare, Analyse Fresenius Kabi Onco. with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FRESENIUS KABI ONCO. vs TEVA PHARMA (Israel) - Comparison Results

FRESENIUS KABI ONCO.     Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FRESENIUS KABI ONCO.   TEVA PHARMA
EQUITY SHARE DATA
    FRESENIUS KABI ONCO.
Mar-13
TEVA PHARMA
Dec-13
FRESENIUS KABI ONCO./
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1763,112-   
Low Rs792,704-   
Sales per share (Unadj.) Rs37.71,786.1-  
Earnings per share (Unadj.) Rs5.1111.6-  
Cash flow per share (Unadj.) Rs6.7255.9-  
Dividends per share (Unadj.) Rs097.67-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs42.51,984.0-  
Shares outstanding (eoy) m158.23848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.6 207.4%   
Avg P/E ratio x25.026.1 95.9%  
P/CF ratio (eoy) x18.911.4 166.6%  
Price / Book Value ratio x3.01.5 204.1%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m20,1352,465,848 0.8%   
No. of employees `0001.244.9 2.6%   
Total wages/salary Rs m7030-   
Avg. sales/employee Rs Th5,176.233,699.2 15.4%   
Avg. wages/employee Rs Th610.40-   
Avg. net profit/employee Rs Th699.62,105.2 33.2%   
INCOME DATA
Net Sales Rs m5,9631,514,612 0.4%  
Other income Rs m180-   
Total revenues Rs m5,9811,514,612 0.4%   
Gross profit Rs m1,430414,777 0.3%  
Depreciation Rs m258122,428 0.2%   
Interest Rs m-2629,749 -0.1%   
Profit before tax Rs m1,216262,600 0.5%   
Minority Interest Rs m01,193 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-68-172,383 0.0%   
Tax Rs m342-3,206 -10.7%   
Profit after tax Rs m80694,617 0.9%  
Gross profit margin %24.027.4 87.6%  
Effective tax rate %28.1-1.2 -2,304.6%   
Net profit margin %13.56.2 216.3%  
BALANCE SHEET DATA
Current assets Rs m5,1021,022,963 0.5%   
Current liabilities Rs m2,385892,110 0.3%   
Net working cap to sales %45.68.6 527.2%  
Current ratio x2.11.1 186.5%  
Inventory Days Days15091 165.2%  
Debtors Days Days11396 118.1%  
Net fixed assets Rs m5,148494,706 1.0%   
Share capital Rs m1583,728 4.2%   
"Free" reserves Rs m6,5560-   
Net worth Rs m6,7321,682,446 0.4%   
Long term debt Rs m952774,455 0.1%   
Total assets Rs m10,3883,461,373 0.3%  
Interest coverage x-45.89.8 -465.8%   
Debt to equity ratio x0.10.5 30.7%  
Sales to assets ratio x0.60.4 131.2%   
Return on assets %7.53.6 209.0%  
Return on equity %12.05.6 212.9%  
Return on capital %14.64.9 296.1%  
Exports to sales %74.50-   
Imports to sales %24.80-   
Net fx Rs m3,5250-   
CASH FLOW
From Operations Rs m1,274241,351 0.5%  
From Investments Rs m-1,204-85,520 1.4%  
From Financial Activity Rs m-196-289,516 0.1%  
Net Cashflow Rs m-126-133,686 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.56 Rs / USD

Compare FRESENIUS KABI ONCO. With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare FRESENIUS KABI ONCO. With: NATCO PHARMA  SANOFI INDIA  DIVIS LABORATORIES  LUPIN  DR. REDDYS LAB  



Today's Market

6 Reasons Why Sensex Plunged 1,708 Points Today(Closing)

Indian share markets witnessed huge selling pressure today as fears that the government could go for stricter lockdowns.

Related Views On News

Most Popular

A Critical Update on the Market (Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy (Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers (Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

India's Revival: A Once-in-a-generation Wealth Making Opportunity
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

FRESENIUS KABI ONCO. SHARE PRICE


Jan 2, 2014 (Close)

TRACK FRESENIUS KABI ONCO.

  • Track your investment in FRESENIUS KABI ONCO. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FRESENIUS KABI ONCO.

FRESENIUS KABI ONCO. 8-QTR ANALYSIS

COMPARE FRESENIUS KABI ONCO. WITH

FEATURED VIDEOS

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

Kalyan Jewellers IPO: An Honest View

More Featured Videos

MARKET STATS